ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 103 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $942,109 | +1094.9% | 101,302 | +1173.3% | 0.00% | – |
| Q1 2024 | $78,844 | +87.5% | 7,956 | -38.9% | 0.00% | – |
| Q4 2023 | $42,045 | -84.8% | 13,017 | -75.0% | 0.00% | – |
| Q3 2023 | $276,343 | -47.0% | 52,042 | -4.9% | 0.00% | -100.0% |
| Q2 2023 | $521,434 | -10.4% | 54,715 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $581,878 | -26.1% | 52,898 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $786,886 | -20.3% | 53,168 | +3.0% | 0.00% | -50.0% |
| Q3 2022 | $987,000 | +13.8% | 51,625 | +26.9% | 0.00% | +100.0% |
| Q2 2022 | $867,000 | +34.2% | 40,693 | +21.4% | 0.00% | 0.0% |
| Q1 2022 | $646,000 | -14.1% | 33,524 | -7.6% | 0.00% | 0.0% |
| Q4 2021 | $752,000 | -11.3% | 36,263 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $848,000 | -18.5% | 35,513 | -6.9% | 0.00% | 0.0% |
| Q2 2021 | $1,041,000 | +3.2% | 38,143 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $1,009,000 | +14.5% | 34,863 | +11.3% | 0.00% | 0.0% |
| Q4 2020 | $881,000 | +9.9% | 31,322 | +14.5% | 0.00% | 0.0% |
| Q3 2020 | $802,000 | +85.6% | 27,357 | +91.4% | 0.00% | 0.0% |
| Q2 2020 | $432,000 | -8.3% | 14,291 | -9.6% | 0.00% | 0.0% |
| Q1 2020 | $471,000 | – | 15,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |